<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Anal Chem</journal-id>
    <journal-id journal-id-type="iso-abbrev">Anal Chem</journal-id>
    <journal-id journal-id-type="publisher-id">ac</journal-id>
    <journal-id journal-id-type="coden">ancham</journal-id>
    <journal-title-group>
      <journal-title>Analytical Chemistry</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0003-2700</issn>
    <issn pub-type="epub">1520-6882</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10469370</article-id>
    <article-id pub-id-type="pmid">37584663</article-id>
    <article-id pub-id-type="doi">10.1021/acs.analchem.3c02039</article-id>
    <article-categories>
      <subj-group>
        <subject>Technical Note</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>LORA, Lipid
Over-Representation Analysis Based on
Structural Information</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Vondrackova</surname>
          <given-names>Michaela</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5885-4568</contrib-id>
        <name>
          <surname>Kopczynski</surname>
          <given-names>Dominik</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6540-6875</contrib-id>
        <name>
          <surname>Hoffmann</surname>
          <given-names>Nils</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7034-4536</contrib-id>
        <name>
          <surname>Kuda</surname>
          <given-names>Ondrej</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label><institution>Institute
of Physiology, Czech Academy of Sciences</institution>, Videnska 1083, 14220 Prague, <country>Czechia</country></aff>
      <aff id="aff2"><label>‡</label>Institute
of Analytical Chemistry, <institution>University of Vienna</institution>, 1090 Vienna, <country>Austria</country></aff>
      <aff id="aff3"><label>§</label>Forschungszentrum
Jülich, <institution>Institute of Bio- and Geosciences
(IBG-5)</institution>, 52428 Jülich, <country>Germany</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>ondrej.kuda@fgu.cas.cz</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>08</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>29</day>
      <month>08</month>
      <year>2023</year>
    </pub-date>
    <volume>95</volume>
    <issue>34</issue>
    <fpage>12600</fpage>
    <lpage>12604</lpage>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>05</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>08</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0003" id="ab-tgr1"/>
      </p>
      <p>With the increasing number of lipidomic studies, there
is a need
for an efficient and automated analysis of lipidomic data. One of
the challenges faced by most existing approaches to lipidomic data
analysis is lipid nomenclature. The systematic nomenclature of lipids
contains all available information about the molecule, including its
hierarchical representation, which can be used for statistical evaluation.
The Lipid Over-Representation Analysis (LORA) web application (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>) analyzes this information using the Java-based Goslin framework,
which translates lipid names into a standardized nomenclature. Goslin
provides the level of lipid hierarchy, including information on headgroups,
acyl chains, and their modifications, up to the “complete structure”
level. LORA allows the user to upload the experimental query and reference
data sets, select a grammar for lipid name normalization, and then
process the data. The user can then interactively explore the results
and perform lipid over-representation analysis based on selected criteria.
The results are graphically visualized according to the lipidome hierarchy.
The lipids present in the most over-represented terms (lipids with
the highest number of enriched shared structural features) are defined
as Very Important Lipids (VILs). For example, the main result of a
demo data set is the information that the query is significantly enriched
with “glycerophospholipids” containing “acyl
20:4” at the “<italic>sn</italic>-2 position”.
These terms define a set of VILs (e.g., PC 18:2/20:4;O and PE 16:0/20:4(5,8,10,14);OH).
All results, graphs, and visualizations are summarized in a report.
LORA is a tool focused on the smart mining of epilipidomics data sets
to facilitate their interpretation at the molecular level.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>European Cooperation in Science and Technology</institution>
            <institution-id institution-id-type="doi">10.13039/501100000921</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CA19105</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Akademie Ved CeskÃ© Republiky</institution>
            <institution-id institution-id-type="doi">10.13039/501100004240</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>LQ200111901</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Ministerstvo ZdravotnictvÃ­ CeskÃ© Republiky</institution>
            <institution-id institution-id-type="doi">10.13039/501100003243</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NV190200118</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Ministerstvo Å kolstvÃ­, MlÃ¡deÅ¾e a TelovÃ½chovy</institution>
            <institution-id institution-id-type="doi">10.13039/501100001823</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>LX22NPO5104</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ac3c02039</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ac3c02039</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Recent advances in analytical techniques
and their routine use
in screening pipelines push forward our ability to provide a full
structural characterization of lipid species in complex biological
matrices. The stereospecifically numbered (<italic>sn</italic>) position
of the acyl/alkyl chain on the glycerol backbone,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> double bond position and stereochemistry within acyl/alkyl
chains,<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> and configuration of chiral centers<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> can be assigned using a combination of advanced
separation and ion activation techniques.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> The emerging challenge is to correctly and systematically annotate
the lipid species<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and consider the high
structural diversity of modified lipid species, generally referred
to as the “epilipidome”.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Correctly annotated and standardized lipid data sets represent an
information source for further FAIR data mining.</p>
    <p>Over-Representation
Analysis (ORA) is a simple statistical method
that determines whether an a priori-defined set of variables is more
present (over-represented) in a subset of variables than would be
expected by chance. Two main bioinformatics tools for over-representation
analysis of lipidomics data sets are available: (1) LION,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> a lipid ontology tool that associates &gt;50,000
lipid species to biophysical, chemical, and cell biological features
and (2) Lipid Mini-On,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> an open-source
tool that performs lipid enrichment analyses and visualizations of
lipidomics data. Both tools use custom-defined lipid databases, specific
nomenclatures, and parsing functions to mine data from lipid names.
However, these tools lack the power to exploit the hierarchical nature
of lipid structures (e.g., <italic>sn</italic> position, double bond
position) and leave the data unmined.</p>
    <p>The goal of the LORA project
was to build a bioinformatics tool
based on Goslin, a systematic grammar-based lipid library, to facilitate
the statistical evaluation of lipid structural information and to
support international standardization of lipidomics nomenclature.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup></p>
  </sec>
  <sec id="sec2">
    <title>Methods</title>
    <sec id="sec2.1">
      <title>Lipid Identifiers and Goslin</title>
      <p>Bioinformatic tools for
lipid ORA require lipid names or database identifiers. We used jGoslin,
the Java implementation of Goslin,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> which
parses the submitted lipid names and translates them into a normalized
hierarchical representation (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Table S1</ext-link>).
jGoslin supports lipid names based on LIPID MAPS, SwissLipids, HMDB,
and Shorthand nomenclature. Lipid classes implemented in Goslin are
periodically updated as new lipid classes are discovered.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Epilipidome nomenclature can be converted to
a compatible format by LipidLynxX.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p>
    </sec>
    <sec id="sec2.2">
      <title>Data Sets</title>
      <p>The lipid data sets used in this work refer
to four published data sets from lipidomic studies in humans: (1)
DEMO 1: Cachexia, body weight stable vs cachectic patients (human
epicardial adipose tissue),<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> (2) DEMO
2: AdipoAtlas, obese vs lean patients (human white adipose tissue),<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> (3) DEMO 3: Lipid Mini-On demo data set (human
lung endothelial lipidome),<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (4) technical
DEMO 4: oxidized membrane lipids (human platelets) at “Complete
structure level”, combined with phospholipids at “Structure
defined” level (mouse liver), and a Goslin performance test
file.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> A list of
query lipids, the whole reference lipidome (codomain), LORA manual,
and the LORA report for each data set is available in the LORA web
application (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>). The LORA manual describes how to prepare query and reference lipidome
lists.</p>
    </sec>
    <sec id="sec2.3">
      <title>Implementation of ORA</title>
      <p>Two enrichment tests were used
to perform ORA: (1) Fisher exact test (scipy.stats.fisher_exact) with
“two-sided”, “less”, “greater”
alternatives and (2) hypergeometric test (scipy.stats.hypergeom) from
SciPy.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Multiple comparisons were adjusted
using the Bonferroni, Holm–Bonferroni, or Benjamini–Hochberg
procedure (the classic False Discovery Rate, FDR).<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref></sup> The ORA was performed at each level of the nomenclature hierarchy
and on structural features provided by Goslin to correct for the set
size effect.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Additional parameters (grouped
number of carbon atoms per acyl chain: less than 16, 16–18,
and more than 18; and the number of double bonds: 0, saturated; 1,
monounsaturated; 2 and more, polyunsaturated) were included to facilitate
biological interpretation of the data. UpSet plots provide visualization
of term intersections.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The visualization
of nomenclature levels was implemented via Biopython.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> The lipidome was converted to phyloXML format, an XML language
designed to describe phylogenetic trees (or networks) and associated
data,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> and the pseudophylogenetic distances
(radii of the spheres/levels) were optimized for the hierarchical
structure of the lipidome. Only the CATEGORY and CLASS levels are
labeled to optimize space use and prevent overlapping labels. The
Cytoscape network was built to visualize the quantitative data and
statistics.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results</title>
    <sec id="sec3.1">
      <title>LORA, a Web-Based Tool for Lipid Over-Representation Analysis</title>
      <p>We developed LORA as a web-based interactive tool using Python
3.10, Dash, and Plotly packages.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> The application
uses a tabular layout. The query and reference lists of lipids are
uploaded, processed, and parsed via Goslin. Users can change the ORA
parameters, perform the analysis, interact with the plots, and download
the report (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). LORA is available as a web service (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>), and the source code is hosted at GitHub <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/IPHYS-Bioinformatics/LORA">https://github.com/IPHYS-Bioinformatics/LORA</uri> under the terms of liberal open source licenses.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>LORA pipeline. User data
(reference and query lipid names) are
processed using Goslin. The lipidome is visualized as a dendrogram,
and LORA is performed. Enrichment results are summarized in a table,
which is further processed to a lipid network and an UpSet plot.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0001" id="gr1" position="float"/>
      </fig>
      <p>The primary output of ORA is a set of over-represented
terms. The
terms are defined based on the nomenclature levels and structural
characteristics of the lipidome parsed by Goslin, e.g., “Total
number of carbon atoms”, “Fatty acid #1 <italic>sn</italic> position”, Total #O, etc.</p>
      <p>LORA is the first tool that
uses smart text mining and extracts
all available structural information from a provided lipid identifier.
Therefore, enrichment based on double bond positions (location and
conformation), bond type (ester and ether), and modifications (oxidized
and cyclized) can be calculated. Human adipose tissue lipidomes (DEMO
1 and DEMO 2) demonstrate how LORA mines the information from widely
used LC–MS lipidomic pipelines.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref></sup> The human
lung lipidome data set in DEMO 3 comes from Lipid Mini-On test files.
The technical DEMO 4 data set contains a collection of (modified)
lipids defined up to “Complete structure” to illustrate
the potential use.</p>
    </sec>
    <sec id="sec3.2">
      <title>Shared Structural Characteristics of Over-Represented Lipids</title>
      <p>The idea behind ORA is that we can infer a smaller set of structural
characteristics for a set of significantly altered lipids, which reduces
the dimensionality and defines the essential features of the query
data. However, we can also take the sets of structural characteristics,
explore their intersections, and find the lipid molecule(s) that best
represent the set of significantly altered lipids. The lipids present
in the most over-represented terms (lipids with the highest number
of term intersections) are defined as Very Important Lipids (VILs). <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> show the analysis of DEMO
4. <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> defines
the seven over-represented terms, and the UpSet plot in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> highlights the common patterns.
The green cluster defines 13 lipids that share structural features
in four over-represented terms (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> B and C). For example, one output is “The query
lipids are statistically significantly enriched in glycerophospholipids
containing 20:4 acyl at the <italic>sn</italic>-2 position”.</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Summary of Over-Represented Terms
from DEMO 4 Calculated at Alpha Level 0.001 with FDR Correction</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">Term (Group/Classifier)</th>
              <th style="border:none;" align="center">Goslin Level</th>
              <th style="border:none;" align="center">No. Query</th>
              <th style="border:none;" align="center">No. Reference</th>
              <th style="border:none;" align="center"><italic>p</italic>-value</th>
              <th style="border:none;" align="center">Odds Ratio</th>
              <th style="border:none;" align="center">FDR</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;">Acyls 16:1</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">18/556</td>
              <td style="border:none;">4.30e-06</td>
              <td style="border:none;">7.0646</td>
              <td style="border:none;">0</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">15/68</td>
              <td style="border:none;">26/556</td>
              <td style="border:none;">5.44e-06</td>
              <td style="border:none;">5.7692</td>
              <td style="border:none;">0</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4</td>
              <td style="border:none;">SN POSITION</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">19/556</td>
              <td style="border:none;">6.63e-06</td>
              <td style="border:none;">6.6804</td>
              <td style="border:none;">0.0001</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 16:1 within Glycerophospholipids [GP]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">17/448</td>
              <td style="border:none;">2.36e-05</td>
              <td style="border:none;">5.9925</td>
              <td style="border:none;">0.0002</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4 within Glycerophospholipids
[GP]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">15/68</td>
              <td style="border:none;">24/448</td>
              <td style="border:none;">2.86e-05</td>
              <td style="border:none;">5.0000</td>
              <td style="border:none;">0.0002</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4 within Glycerophospholipids
[GP]</td>
              <td style="border:none;">SN POSITION</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">18/448</td>
              <td style="border:none;">3.64e-05</td>
              <td style="border:none;">5.6465</td>
              <td style="border:none;">0.0004</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 16:1 within Glycerophosphocholines [GP01]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">11/26</td>
              <td style="border:none;">14/148</td>
              <td style="border:none;">1.00e-4</td>
              <td style="border:none;">7.0190</td>
              <td style="border:none;">0.0005</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Interpretation of the LORA results. (A) UpSet plot showing the
intersection of over-represented terms (structural characteristics)
from <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. Cardinality
is sorted according to the total number of term intersections. (B)
Intersection of four terms defining the green cluster. (C) Green cluster
containing 13 lipids which share a structural feature “20:4”
at the <italic>sn</italic>-2 position.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0002" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec3.3">
      <title>UpSet plot Visualization of Term Intersections</title>
      <p>The
major challenge in evaluating the over-represented structural characteristics
is the enormous number of set intersections if the number of sets
exceeds a reasonable threshold. In the case of one to three sets,
the Venn or Euler diagrams, which visualize all possible logical relations
between the sets, can be used. In the case of two to 20 sets, the
UpSet plot provides a comprehensive visualization.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The UpSet plot helps identify the main structural features
of enriched lipids and highlights the VILs in a graphical representation
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Connected
black dots represent the intersection of the terms labeled on top.
The term intersection size (cardinality bar plot) represents the number
of lipids that have this specific set of structural features in common.
The <italic>p</italic>-values belong to the particular lipids within
individual terms (<italic>n</italic> lipids × <italic>m</italic> terms). The bar graph at the bottom shows how many lipids belong
to the term. The plot is interactive, and a table showing all lipids
within the specific intersection (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C) is generated upon clicking on the cardinality
bar.</p>
    </sec>
    <sec id="sec3.4">
      <title>Hierarchical Tree Visualization of the Lipidome</title>
      <p>Goslin
provides information on the hierarchical level of the lipids in the
data set. We can visualize the information as a circular tree map
(dendrogram) showing part-to-whole relationships and the level of
structural details provided by the analytical method. The graph itself
is interactive, and each lipid level can be explored via a tooltip
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Figure S1A</ext-link>). The lipidome enrichment down
to the LIPID MAPS SUBCLASS level can be visualized as an interactive
network in Cytoscape, which allows for the mapping of statistical
data onto nodes and edges (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Figure S1B</ext-link>).</p>
    </sec>
    <sec id="sec3.5">
      <title>Report</title>
      <p>LORA provides output in a zip archive containing
a PDF report, parameter settings, over-representation analysis results,
VIL table, UpSet plot, intersection tables, circular tree map, and
the lipidome network in SVG, JPG, phyloXML, interactive HTML, XLSX,
and Cytoscape formats, respectively.</p>
    </sec>
    <sec id="sec3.6">
      <title>Limitations</title>
      <p>Lipid modifications, including oxidation,
nitration, or halogenation, represent a new level of nomenclature
complexity that extremely expands the search space.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Testing all structural characteristics up to “Complete
structure level” would require computational resources that
would not balance information gain. Therefore, the application does
not implement “rare” features like the position of lipid
modification or enantiomers. Lipid names in conflict with the hierarchical
structure of shorthand notation (e.g., PC 16:1(7)_16:1(9)) will be
converted to the closest valid level (e.g., PC 16:1_16:1). Goslin
grammars (version 2) are currently limited to the most common set
of lipid classes and do not consider multiple class categorization
of lipids in LIPID MAPS (e.g., [FA01] Fatty Acid Conjugates and [FA02]
Octadecanoids).<sup><xref ref-type="bibr" rid="ref11">11</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Discussion and Conclusion</title>
    <p>Lipidomic analyses are usually
performed to gain insight into system
lipid metabolism, and ORA helps reduce the observation’s dimensionality.
In contrast to transcriptomics, where the ORA results can be directly
used in pathways analysis,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> functional
pathway schemes for lipids are largely unavailable. The major problems
are (1) the inability to assign a lipid database identifier to experimentally
generated information describing the lipid molecule at the level of
enzyme–substrate specificity,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> (2)
the continuous remodeling of the head groups and acyl chains by many
enzymes simultaneously, and (3) the lack of curated lipid pathways
at various nomenclature levels (with a few exceptions<sup><xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup>). Generalized databases such as KEGG do not consider the structural
diversity of lipids and often blur together multiple biological processes,
thus compromising the biological interpretation. To overcome the problems,
LORA builds on the Goslin standardization approach and known lipid
structural characteristics provided by novel analytical techniques.
Instead of relying on predefined schemes, LORA creates a set of over-represented
terms based solely on provided structural information and statistical
tests. The user can either directly interpret this set or reshape
it by the UpSet plot to highlight the most common structural features
and their representatives (lipid species).</p>
    <p>The most common set
visualization approach—Venn diagrams—do
not scale beyond three or four sets. The UpSet plot, in contrast,
is well suited for the quantitative analysis of data with more than
three sets. When more than seven sets intersect, the advanced UpSet
plots allowing aggregation and grouping should be used to reduce the
dimensionality.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> We optimized the UpSet
plot implemented in LORA for common lipidomics data sets. We limited
the visualization to at most 13 terms because the calculation costs
of all possible term intersections grow exponentially. Of note, the
choice of lipid structural features, similar to the pathway database,
used in ORA can have a much stronger effect on the enrichment results
than the statistical corrections used in these analyses.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup></p>
    <p>LORA is a tool focused on the expanding
technologies in (epi)lipidomics
that allow for more precise identification of lipid structures. Routine
use of supercritical fluid chromatography, ion mobility spectrometry,
ion–molecule reactions, or derivatization techniques to specifically
target double bond positions will provide further levels of detail
to lead toward the full structural characterization of lipids. LORA
mines this information-rich data set and helps interpret lipid structural
features and over-represented terms using visualization tools. It
is the next step toward understanding lipidomic data sets at the molecular
level.</p>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The
Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.analchem.3c02039?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.3c02039</ext-link>.<list id="silist" list-type="simple"><list-item><p>Supplementary figures and texts (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_si_001.pdf">
        <caption>
          <p>ac3c02039_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes2">
    <title>Author Contributions</title>
    <p>Conceptualization:
O.K. Data curation: M.V. and O.K. Formal analysis: M.V., D.K., and
N.H. Funding acquisition: O.K. Investigation: M.V. and O.K. Methodology:
M.V. and O.K. Project administration: O.K. Resources: D.K., N.H.,
and O.K. Software: M.V., D.K., N.H., and O.K. Supervision: O.K. Validation:
D.K. and N.H. Visualization: M.V. and O.K. Writing–original
draft: M.V. and O.K. Writing–review and editing: M.V., N.H.,
and O.K.</p>
  </notes>
  <notes notes-type="COI-statement" id="notes3">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work is supported by the project National Institute
for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES,
ID Project No. LX22NPO5104) – Funded by the European Union
– Next Generation EU, Ministry of Health [NV19-02-00118], the
Czech Academy of Sciences [Lumina Quaeruntur LQ200111901], and COST
Action CA19105 - Pan-European Network in Lipidomics and EpiLipidomics
(EpiLipidNET), supported by COST (European Cooperation in Science
and Technology).</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Šala</surname><given-names>M.</given-names></name>; <name><surname>Lísa</surname><given-names>M.</given-names></name>; <name><surname>Campbell</surname><given-names>J. L.</given-names></name>; <name><surname>Holčapek</surname><given-names>M.</given-names></name><article-title>Determination
of triacylglycerol regioisomers using differential mobility spectrometry</article-title>. <source>Rapid Commun. Mass Spectrom.</source><year>2016</year>, <volume>30</volume>, <fpage>256</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1002/rcm.7430</pub-id>.<pub-id pub-id-type="pmid">27071217</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Menzel</surname><given-names>J. P.</given-names></name>; <name><surname>Young</surname><given-names>R. S. E.</given-names></name>; <name><surname>Benfield</surname><given-names>A. H.</given-names></name>; <name><surname>Scott</surname><given-names>J. S.</given-names></name>; <name><surname>Wongsomboon</surname><given-names>P.</given-names></name>; <name><surname>Cudlman</surname><given-names>L.</given-names></name>; <name><surname>Cvacka</surname><given-names>J.</given-names></name>; <name><surname>Butler</surname><given-names>L. M.</given-names></name>; <name><surname>Henriques</surname><given-names>S. T.</given-names></name>; <name><surname>Poad</surname><given-names>B. L. J.</given-names></name>; <name><surname>Blanksby</surname><given-names>S. J.</given-names></name><article-title>Ozone-enabled
fatty acid discovery
reveals unexpected diversity in the human lipidome</article-title>. <source>Nat. Commun.</source><year>2023</year>, <volume>14</volume>, <fpage>3940</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-39617-9</pub-id>.<pub-id pub-id-type="pmid">37402773</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Ren</surname><given-names>H.</given-names></name>; <name><surname>Triebl</surname><given-names>A.</given-names></name>; <name><surname>Muralidharan</surname><given-names>S.</given-names></name>; <name><surname>Wenk</surname><given-names>M. R.</given-names></name>; <name><surname>Xia</surname><given-names>Y.</given-names></name>; <name><surname>Torta</surname><given-names>F.</given-names></name><article-title>Mapping the distribution
of double bond location isomers in lipids
across mouse tissues</article-title>. <source>Analyst</source><year>2021</year>, <volume>146</volume>, <fpage>3899</fpage>–<lpage>3907</lpage>. <pub-id pub-id-type="doi">10.1039/D1AN00449B</pub-id>.<pub-id pub-id-type="pmid">34009216</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Brezinova</surname><given-names>M.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name>; <name><surname>Hansikova</surname><given-names>J.</given-names></name>; <name><surname>Rombaldova</surname><given-names>M.</given-names></name>; <name><surname>Balas</surname><given-names>L.</given-names></name>; <name><surname>Bardova</surname><given-names>K.</given-names></name>; <name><surname>Durand</surname><given-names>T.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Cerna</surname><given-names>M.</given-names></name>; <name><surname>Stranak</surname><given-names>Z.</given-names></name>; <name><surname>Kopecky</surname><given-names>J.</given-names></name><article-title>Levels of
palmitic
acid ester of hydroxystearic acid (PAHSA) are reduced in the breast
milk of obese mothers</article-title>. <source>BBA MCBL</source><year>2018</year>, <volume>1863</volume>, <fpage>126</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2017.11.004</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Hancock</surname><given-names>S. E.</given-names></name>; <name><surname>Poad</surname><given-names>B. L.</given-names></name>; <name><surname>Batarseh</surname><given-names>A.</given-names></name>; <name><surname>Abbott</surname><given-names>S. K.</given-names></name>; <name><surname>Mitchell</surname><given-names>T. W.</given-names></name><article-title>Advances
and unresolved challenges in the structural characterization of isomeric
lipids</article-title>. <source>Anal. Biochem.</source><year>2017</year>, <volume>524</volume>, <fpage>45</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2016.09.014</pub-id>.<pub-id pub-id-type="pmid">27651163</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Liebisch</surname><given-names>G.</given-names></name>; <name><surname>Fahy</surname><given-names>E.</given-names></name>; <name><surname>Aoki</surname><given-names>J.</given-names></name>; <name><surname>Dennis</surname><given-names>E. A.</given-names></name>; <name><surname>Durand</surname><given-names>T.</given-names></name>; <name><surname>Ejsing</surname><given-names>C. S.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name>; <name><surname>Feussner</surname><given-names>I.</given-names></name>; <name><surname>Griffiths</surname><given-names>W. J.</given-names></name>; <name><surname>Kofeler</surname><given-names>H.</given-names></name>; <name><surname>Merrill</surname><given-names>A. H.</given-names><suffix>Jr</suffix></name>; <name><surname>Murphy</surname><given-names>R. C.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name>; <name><surname>Oskolkova</surname><given-names>O.</given-names></name>; <name><surname>Subramaniam</surname><given-names>S.</given-names></name>; <name><surname>Wakelam</surname><given-names>M. J. O.</given-names></name>; <name><surname>Spener</surname><given-names>F.</given-names></name><article-title>Update on
LIPID MAPS classification,
nomenclature, and shorthand notation for MS-derived lipid structures</article-title>. <source>J. Lipid Res.</source><year>2020</year>, <volume>61</volume>, <fpage>1539</fpage>–<lpage>1555</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.S120001025</pub-id>.<pub-id pub-id-type="pmid">33037133</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Damiani</surname><given-names>T.</given-names></name>; <name><surname>Bonciarelli</surname><given-names>S.</given-names></name>; <name><surname>Thallinger</surname><given-names>G. G.</given-names></name>; <name><surname>Koehler</surname><given-names>N.</given-names></name>; <name><surname>Krettler</surname><given-names>C. A.</given-names></name>; <name><surname>Salihoglu</surname><given-names>A. K.</given-names></name>; <name><surname>Korf</surname><given-names>A.</given-names></name>; <name><surname>Pauling</surname><given-names>J. K.</given-names></name>; <name><surname>Pluskal</surname><given-names>T.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Goracci</surname><given-names>L.</given-names></name><article-title>Software and Computational Tools for LC-MS-Based Epilipidomics:
Challenges and Solutions</article-title>. <source>Anal. Chem.</source><year>2023</year>, <volume>95</volume>, <fpage>287</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.2c04406</pub-id>.<pub-id pub-id-type="pmid">36625108</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Molenaar</surname><given-names>M. R.</given-names></name>; <name><surname>Jeucken</surname><given-names>A.</given-names></name>; <name><surname>Wassenaar</surname><given-names>T. A.</given-names></name>; <name><surname>van de Lest</surname><given-names>C. H. A.</given-names></name>; <name><surname>Brouwers</surname><given-names>J. F.</given-names></name>; <name><surname>Helms</surname><given-names>J. B.</given-names></name><article-title>LION/web: a web-based
ontology enrichment
tool for lipidomic data analysis</article-title>. <source>Gigascience</source><year>2019</year>, <volume>8</volume>, <fpage>giz061</fpage><pub-id pub-id-type="doi">10.1093/gigascience/giz061</pub-id>.<pub-id pub-id-type="pmid">31141612</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Clair</surname><given-names>G.</given-names></name>; <name><surname>Reehl</surname><given-names>S.</given-names></name>; <name><surname>Stratton</surname><given-names>K. G.</given-names></name>; <name><surname>Monroe</surname><given-names>M. E.</given-names></name>; <name><surname>Tfaily</surname><given-names>M. M.</given-names></name>; <name><surname>Ansong</surname><given-names>C.</given-names></name>; <name><surname>Kyle</surname><given-names>J. E.</given-names></name><article-title>Lipid Mini-On:
mining and ontology
tool for enrichment analysis of lipidomic data</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume>, <fpage>4507</fpage>–<lpage>4508</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz250</pub-id>.<pub-id pub-id-type="pmid">30977807</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Kopczynski</surname><given-names>D.</given-names></name>; <name><surname>Hoffmann</surname><given-names>N.</given-names></name>; <name><surname>Peng</surname><given-names>B.</given-names></name>; <name><surname>Ahrends</surname><given-names>R.</given-names></name><article-title>Goslin: A
Grammar of
Succinct Lipid Nomenclature</article-title>. <source>Anal. Chem.</source><year>2020</year>, <volume>92</volume>, <fpage>10957</fpage>–<lpage>10960</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.0c01690</pub-id>.<pub-id pub-id-type="pmid">32589019</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Kopczynski</surname><given-names>D.</given-names></name>; <name><surname>Hoffmann</surname><given-names>N.</given-names></name>; <name><surname>Peng</surname><given-names>B.</given-names></name>; <name><surname>Liebisch</surname><given-names>G.</given-names></name>; <name><surname>Spener</surname><given-names>F.</given-names></name>; <name><surname>Ahrends</surname><given-names>R.</given-names></name><article-title>Goslin 2.0 Implements
the Recent Lipid Shorthand Nomenclature
for MS-Derived Lipid Structures</article-title>. <source>Anal. Chem.</source><year>2022</year>, <volume>94</volume>, <fpage>6097</fpage>–<lpage>6101</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.1c05430</pub-id>.<pub-id pub-id-type="pmid">35404045</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="report" id="cit12"><person-group><name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name></person-group><article-title>LipidLynxX: a data transfer
hub to support integration
of large scale lipidomics datasets</article-title>. <source>bioRxiv
Preprint</source>, <year>2020</year>. <pub-id pub-id-type="doi">10.1101/2020.04.09.033894</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Janovska</surname><given-names>P.</given-names></name>; <name><surname>Melenovsky</surname><given-names>V.</given-names></name>; <name><surname>Svobodova</surname><given-names>M.</given-names></name>; <name><surname>Havlenova</surname><given-names>T.</given-names></name>; <name><surname>Kratochvilova</surname><given-names>H.</given-names></name>; <name><surname>Haluzik</surname><given-names>M.</given-names></name>; <name><surname>Hoskova</surname><given-names>E.</given-names></name>; <name><surname>Pelikanova</surname><given-names>T.</given-names></name>; <name><surname>Kautzner</surname><given-names>J.</given-names></name>; <name><surname>Monzo</surname><given-names>L.</given-names></name>; <name><surname>Jurcova</surname><given-names>I.</given-names></name>; <name><surname>Adamcova</surname><given-names>K.</given-names></name>; <name><surname>Lenkova</surname><given-names>L.</given-names></name>; <name><surname>Buresova</surname><given-names>J.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name>; <name><surname>Cajka</surname><given-names>T.</given-names></name>; <name><surname>Kopecky</surname><given-names>J.</given-names></name><article-title>Dysregulation of epicardial
adipose tissue in cachexia due to heart failure: the role of natriuretic
peptides and cardiolipin</article-title>. <source>J. Cachexia Sarcopenia
Muscle</source><year>2020</year>, <volume>11</volume>, <fpage>1614</fpage>–<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1002/jcsm.12631</pub-id>.<pub-id pub-id-type="pmid">33084249</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Lange</surname><given-names>M.</given-names></name>; <name><surname>Angelidou</surname><given-names>G.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Criscuolo</surname><given-names>A.</given-names></name>; <name><surname>Schiller</surname><given-names>J.</given-names></name>; <name><surname>Bluher</surname><given-names>M.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name><article-title>AdipoAtlas:
A reference
lipidome for human white adipose tissue</article-title>. <source>Cell
Rep. Med.</source><year>2021</year>, <volume>2</volume>, <fpage>100407</fpage><pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100407</pub-id>.<pub-id pub-id-type="pmid">34755127</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Lauder</surname><given-names>S. N.</given-names></name>; <name><surname>Allen-Redpath</surname><given-names>K.</given-names></name>; <name><surname>Slatter</surname><given-names>D. A.</given-names></name>; <name><surname>Aldrovandi</surname><given-names>M.</given-names></name>; <name><surname>O’Connor</surname><given-names>A.</given-names></name>; <name><surname>Farewell</surname><given-names>D.</given-names></name>; <name><surname>Percy</surname><given-names>C. L.</given-names></name>; <name><surname>Molhoek</surname><given-names>J. E.</given-names></name>; <name><surname>Rannikko</surname><given-names>S.</given-names></name>; <name><surname>Tyrrell</surname><given-names>V. J.</given-names></name>; <name><surname>Ferla</surname><given-names>S.</given-names></name>; <name><surname>Milne</surname><given-names>G. L.</given-names></name>; <name><surname>Poole</surname><given-names>A. W.</given-names></name>; <name><surname>Thomas</surname><given-names>C. P.</given-names></name>; <name><surname>Obaji</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>P. R.</given-names></name>; <name><surname>Jones</surname><given-names>S. A.</given-names></name>; <name><surname>de Groot</surname><given-names>P. G.</given-names></name>; <name><surname>Urbanus</surname><given-names>R. T.</given-names></name>; <name><surname>Horkko</surname><given-names>S.</given-names></name>; <name><surname>Uderhardt</surname><given-names>S.</given-names></name>; <name><surname>Ackermann</surname><given-names>J.</given-names></name>; <name><surname>Vince Jenkins</surname><given-names>P.</given-names></name>; <name><surname>Brancale</surname><given-names>A.</given-names></name>; <name><surname>Kronke</surname><given-names>G.</given-names></name>; <name><surname>Collins</surname><given-names>P. W.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name><article-title>Networks
of enzymatically oxidized membrane lipids support calcium-dependent
coagulation factor binding to maintain hemostasis</article-title>. <source>Sci. Signal</source><year>2017</year>, <volume>10</volume>, <fpage>eaan2787</fpage><pub-id pub-id-type="doi">10.1126/scisignal.aan2787</pub-id>.<pub-id pub-id-type="pmid">29184033</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Virtanen</surname><given-names>P.</given-names></name>; <name><surname>Gommers</surname><given-names>R.</given-names></name>; <name><surname>Oliphant</surname><given-names>T. E.</given-names></name>; <name><surname>Haberland</surname><given-names>M.</given-names></name>; <name><surname>Reddy</surname><given-names>T.</given-names></name>; <name><surname>Cournapeau</surname><given-names>D.</given-names></name>; <name><surname>Burovski</surname><given-names>E.</given-names></name>; <name><surname>Peterson</surname><given-names>P.</given-names></name>; <name><surname>Weckesser</surname><given-names>W.</given-names></name>; <name><surname>Bright</surname><given-names>J.</given-names></name>; <name><surname>van der Walt</surname><given-names>S. J.</given-names></name>; <name><surname>Brett</surname><given-names>M.</given-names></name>; <name><surname>Wilson</surname><given-names>J.</given-names></name>; <name><surname>Millman</surname><given-names>K. J.</given-names></name>; <name><surname>Mayorov</surname><given-names>N.</given-names></name>; <name><surname>Nelson</surname><given-names>A. R. J.</given-names></name>; <name><surname>Jones</surname><given-names>E.</given-names></name>; <name><surname>Kern</surname><given-names>R.</given-names></name>; <name><surname>Larson</surname><given-names>E.</given-names></name>; <name><surname>Carey</surname><given-names>C. J.</given-names></name>; et al. <article-title>SciPy 1.0: fundamental algorithms for scientific
computing in Python</article-title>. <source>Nat. Methods</source><year>2020</year>, <volume>17</volume>, <fpage>261</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id>.<pub-id pub-id-type="pmid">32015543</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Chen</surname><given-names>S. Y.</given-names></name>; <name><surname>Feng</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>X.</given-names></name><article-title>A general
introduction to adjustment
for multiple comparisons</article-title>. <source>J. Thorac. Dis.</source><year>2017</year>, <volume>9</volume>, <fpage>1725</fpage>–<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.21037/jtd.2017.05.34</pub-id>.<pub-id pub-id-type="pmid">28740688</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Huang</surname><given-names>D. W.</given-names></name>; <name><surname>Sherman</surname><given-names>B. T.</given-names></name>; <name><surname>Lempicki</surname><given-names>R. A.</given-names></name><article-title>Bioinformatics
enrichment tools:
paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>, <volume>37</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id>.<pub-id pub-id-type="pmid">19033363</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Karp</surname><given-names>P. D.</given-names></name>; <name><surname>Midford</surname><given-names>P. E.</given-names></name>; <name><surname>Caspi</surname><given-names>R.</given-names></name>; <name><surname>Khodursky</surname><given-names>A.</given-names></name><article-title>Pathway size
matters: the influence of pathway granularity on over-representation
(enrichment analysis) statistics</article-title>. <source>BMC Genomics</source><year>2021</year>, <volume>22</volume>, <fpage>191</fpage><pub-id pub-id-type="doi">10.1186/s12864-021-07502-8</pub-id>.<pub-id pub-id-type="pmid">33726670</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Lex</surname><given-names>A.</given-names></name>; <name><surname>Gehlenborg</surname><given-names>N.</given-names></name>; <name><surname>Strobelt</surname><given-names>H.</given-names></name>; <name><surname>Vuillemot</surname><given-names>R.</given-names></name>; <name><surname>Pfister</surname><given-names>H.</given-names></name><article-title>UpSet: Visualization
of Intersecting Sets</article-title>. <source>IEEE Trans Vis Comput.
Graph</source><year>2014</year>, <volume>20</volume>, <fpage>1983</fpage>–<lpage>1992</lpage>. <pub-id pub-id-type="doi">10.1109/TVCG.2014.2346248</pub-id>.<pub-id pub-id-type="pmid">26356912</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Cock</surname><given-names>P. J.</given-names></name>; <name><surname>Antao</surname><given-names>T.</given-names></name>; <name><surname>Chang</surname><given-names>J. T.</given-names></name>; <name><surname>Chapman</surname><given-names>B. A.</given-names></name>; <name><surname>Cox</surname><given-names>C. J.</given-names></name>; <name><surname>Dalke</surname><given-names>A.</given-names></name>; <name><surname>Friedberg</surname><given-names>I.</given-names></name>; <name><surname>Hamelryck</surname><given-names>T.</given-names></name>; <name><surname>Kauff</surname><given-names>F.</given-names></name>; <name><surname>Wilczynski</surname><given-names>B.</given-names></name>; <name><surname>de Hoon</surname><given-names>M. J.</given-names></name><article-title>Biopython: freely
available Python tools for computational molecular biology and bioinformatics</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>1422</fpage>–<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp163</pub-id>.<pub-id pub-id-type="pmid">19304878</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Han</surname><given-names>M. V.</given-names></name>; <name><surname>Zmasek</surname><given-names>C. M.</given-names></name><article-title>phyloXML: XML for evolutionary biology
and comparative
genomics</article-title>. <source>BMC Bioinformatics</source><year>2009</year>, <volume>10</volume>, <fpage>356</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-356</pub-id>.<pub-id pub-id-type="pmid">19860910</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Lopes</surname><given-names>M.</given-names></name>; <name><surname>Brejchova</surname><given-names>K.</given-names></name>; <name><surname>Riecan</surname><given-names>M.</given-names></name>; <name><surname>Novakova</surname><given-names>M.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Cajka</surname><given-names>T.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name><article-title>Metabolomics atlas
of oral 13C-glucose
tolerance test in mice</article-title>. <source>Cell Rep.</source><year>2021</year>, <volume>37</volume>, <fpage>109833</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109833</pub-id>.<pub-id pub-id-type="pmid">34644567</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="book" id="cit24"><person-group person-group-type="allauthors"><name><surname>Van Rossum</surname><given-names>G.</given-names></name>; <name><surname>Drake</surname><given-names>F. L.</given-names></name></person-group><source>Python 3 Reference
Manual</source>; <publisher-name>CreateSpace</publisher-name>: <publisher-loc>Scotts Valley, CA</publisher-loc>, <year>2009</year>.</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="book" id="cit25"><person-group person-group-type="allauthors"><name><surname>Sievert</surname><given-names>C.</given-names></name></person-group><source>Interactive Web-Based
Data Visualization with R, plotly, and shiny</source>; <publisher-name>Chapman and Hall/CRC</publisher-name>: <publisher-loc>FL</publisher-loc>, <year>2020</year>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Martens</surname><given-names>M.</given-names></name>; <name><surname>Ammar</surname><given-names>A.</given-names></name>; <name><surname>Riutta</surname><given-names>A.</given-names></name>; <name><surname>Waagmeester</surname><given-names>A.</given-names></name>; <name><surname>Slenter</surname><given-names>D. N.</given-names></name>; <name><surname>Hanspers</surname><given-names>K.</given-names></name>; <name><surname>Miller</surname><given-names>R. A.</given-names></name>; <name><surname>Digles</surname><given-names>D.</given-names></name>; <name><surname>Lopes</surname><given-names>E. N.</given-names></name>; <name><surname>Ehrhart</surname><given-names>F.</given-names></name>; <name><surname>Dupuis</surname><given-names>L. J.</given-names></name>; <name><surname>Winckers</surname><given-names>L. A.</given-names></name>; <name><surname>Coort</surname><given-names>S. L.</given-names></name>; <name><surname>Willighagen</surname><given-names>E. L.</given-names></name>; <name><surname>Evelo</surname><given-names>C. T.</given-names></name>; <name><surname>Pico</surname><given-names>A. R.</given-names></name>; <name><surname>Kutmon</surname><given-names>M.</given-names></name><article-title>WikiPathways: connecting
communities</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D613</fpage>–<lpage>D621</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1024</pub-id>.<pub-id pub-id-type="pmid">33211851</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Gaud</surname><given-names>C.</given-names></name>; <name><surname>Sousa</surname><given-names>B. C.</given-names></name>; <name><surname>Nguyen</surname><given-names>A.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name>; <name><surname>Wakelam</surname><given-names>M. J. O.</given-names></name>; <name><surname>Andrews</surname><given-names>S.</given-names></name>; <name><surname>Lopez-Clavijo</surname><given-names>A. F.</given-names></name><article-title>BioPAN:
a web-based tool to explore mammalian lipidome metabolic pathways
on LIPID MAPS</article-title>. <source>F1000Res.</source><year>2021</year>, <volume>10</volume>, <fpage>4</fpage><pub-id pub-id-type="doi">10.12688/f1000research.28022.2</pub-id>.<pub-id pub-id-type="pmid">33564392</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Anal Chem</journal-id>
    <journal-id journal-id-type="iso-abbrev">Anal Chem</journal-id>
    <journal-id journal-id-type="publisher-id">ac</journal-id>
    <journal-id journal-id-type="coden">ancham</journal-id>
    <journal-title-group>
      <journal-title>Analytical Chemistry</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0003-2700</issn>
    <issn pub-type="epub">1520-6882</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10469370</article-id>
    <article-id pub-id-type="pmid">37584663</article-id>
    <article-id pub-id-type="doi">10.1021/acs.analchem.3c02039</article-id>
    <article-categories>
      <subj-group>
        <subject>Technical Note</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>LORA, Lipid
Over-Representation Analysis Based on
Structural Information</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Vondrackova</surname>
          <given-names>Michaela</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5885-4568</contrib-id>
        <name>
          <surname>Kopczynski</surname>
          <given-names>Dominik</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6540-6875</contrib-id>
        <name>
          <surname>Hoffmann</surname>
          <given-names>Nils</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7034-4536</contrib-id>
        <name>
          <surname>Kuda</surname>
          <given-names>Ondrej</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label><institution>Institute
of Physiology, Czech Academy of Sciences</institution>, Videnska 1083, 14220 Prague, <country>Czechia</country></aff>
      <aff id="aff2"><label>‡</label>Institute
of Analytical Chemistry, <institution>University of Vienna</institution>, 1090 Vienna, <country>Austria</country></aff>
      <aff id="aff3"><label>§</label>Forschungszentrum
Jülich, <institution>Institute of Bio- and Geosciences
(IBG-5)</institution>, 52428 Jülich, <country>Germany</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>ondrej.kuda@fgu.cas.cz</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>08</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>29</day>
      <month>08</month>
      <year>2023</year>
    </pub-date>
    <volume>95</volume>
    <issue>34</issue>
    <fpage>12600</fpage>
    <lpage>12604</lpage>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>05</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>08</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0003" id="ab-tgr1"/>
      </p>
      <p>With the increasing number of lipidomic studies, there
is a need
for an efficient and automated analysis of lipidomic data. One of
the challenges faced by most existing approaches to lipidomic data
analysis is lipid nomenclature. The systematic nomenclature of lipids
contains all available information about the molecule, including its
hierarchical representation, which can be used for statistical evaluation.
The Lipid Over-Representation Analysis (LORA) web application (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>) analyzes this information using the Java-based Goslin framework,
which translates lipid names into a standardized nomenclature. Goslin
provides the level of lipid hierarchy, including information on headgroups,
acyl chains, and their modifications, up to the “complete structure”
level. LORA allows the user to upload the experimental query and reference
data sets, select a grammar for lipid name normalization, and then
process the data. The user can then interactively explore the results
and perform lipid over-representation analysis based on selected criteria.
The results are graphically visualized according to the lipidome hierarchy.
The lipids present in the most over-represented terms (lipids with
the highest number of enriched shared structural features) are defined
as Very Important Lipids (VILs). For example, the main result of a
demo data set is the information that the query is significantly enriched
with “glycerophospholipids” containing “acyl
20:4” at the “<italic>sn</italic>-2 position”.
These terms define a set of VILs (e.g., PC 18:2/20:4;O and PE 16:0/20:4(5,8,10,14);OH).
All results, graphs, and visualizations are summarized in a report.
LORA is a tool focused on the smart mining of epilipidomics data sets
to facilitate their interpretation at the molecular level.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>European Cooperation in Science and Technology</institution>
            <institution-id institution-id-type="doi">10.13039/501100000921</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CA19105</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Akademie Ved CeskÃ© Republiky</institution>
            <institution-id institution-id-type="doi">10.13039/501100004240</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>LQ200111901</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Ministerstvo ZdravotnictvÃ­ CeskÃ© Republiky</institution>
            <institution-id institution-id-type="doi">10.13039/501100003243</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NV190200118</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Ministerstvo Å kolstvÃ­, MlÃ¡deÅ¾e a TelovÃ½chovy</institution>
            <institution-id institution-id-type="doi">10.13039/501100001823</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>LX22NPO5104</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ac3c02039</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ac3c02039</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Recent advances in analytical techniques
and their routine use
in screening pipelines push forward our ability to provide a full
structural characterization of lipid species in complex biological
matrices. The stereospecifically numbered (<italic>sn</italic>) position
of the acyl/alkyl chain on the glycerol backbone,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> double bond position and stereochemistry within acyl/alkyl
chains,<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> and configuration of chiral centers<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> can be assigned using a combination of advanced
separation and ion activation techniques.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> The emerging challenge is to correctly and systematically annotate
the lipid species<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and consider the high
structural diversity of modified lipid species, generally referred
to as the “epilipidome”.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Correctly annotated and standardized lipid data sets represent an
information source for further FAIR data mining.</p>
    <p>Over-Representation
Analysis (ORA) is a simple statistical method
that determines whether an a priori-defined set of variables is more
present (over-represented) in a subset of variables than would be
expected by chance. Two main bioinformatics tools for over-representation
analysis of lipidomics data sets are available: (1) LION,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> a lipid ontology tool that associates &gt;50,000
lipid species to biophysical, chemical, and cell biological features
and (2) Lipid Mini-On,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> an open-source
tool that performs lipid enrichment analyses and visualizations of
lipidomics data. Both tools use custom-defined lipid databases, specific
nomenclatures, and parsing functions to mine data from lipid names.
However, these tools lack the power to exploit the hierarchical nature
of lipid structures (e.g., <italic>sn</italic> position, double bond
position) and leave the data unmined.</p>
    <p>The goal of the LORA project
was to build a bioinformatics tool
based on Goslin, a systematic grammar-based lipid library, to facilitate
the statistical evaluation of lipid structural information and to
support international standardization of lipidomics nomenclature.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup></p>
  </sec>
  <sec id="sec2">
    <title>Methods</title>
    <sec id="sec2.1">
      <title>Lipid Identifiers and Goslin</title>
      <p>Bioinformatic tools for
lipid ORA require lipid names or database identifiers. We used jGoslin,
the Java implementation of Goslin,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> which
parses the submitted lipid names and translates them into a normalized
hierarchical representation (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Table S1</ext-link>).
jGoslin supports lipid names based on LIPID MAPS, SwissLipids, HMDB,
and Shorthand nomenclature. Lipid classes implemented in Goslin are
periodically updated as new lipid classes are discovered.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Epilipidome nomenclature can be converted to
a compatible format by LipidLynxX.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p>
    </sec>
    <sec id="sec2.2">
      <title>Data Sets</title>
      <p>The lipid data sets used in this work refer
to four published data sets from lipidomic studies in humans: (1)
DEMO 1: Cachexia, body weight stable vs cachectic patients (human
epicardial adipose tissue),<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> (2) DEMO
2: AdipoAtlas, obese vs lean patients (human white adipose tissue),<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> (3) DEMO 3: Lipid Mini-On demo data set (human
lung endothelial lipidome),<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (4) technical
DEMO 4: oxidized membrane lipids (human platelets) at “Complete
structure level”, combined with phospholipids at “Structure
defined” level (mouse liver), and a Goslin performance test
file.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> A list of
query lipids, the whole reference lipidome (codomain), LORA manual,
and the LORA report for each data set is available in the LORA web
application (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>). The LORA manual describes how to prepare query and reference lipidome
lists.</p>
    </sec>
    <sec id="sec2.3">
      <title>Implementation of ORA</title>
      <p>Two enrichment tests were used
to perform ORA: (1) Fisher exact test (scipy.stats.fisher_exact) with
“two-sided”, “less”, “greater”
alternatives and (2) hypergeometric test (scipy.stats.hypergeom) from
SciPy.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Multiple comparisons were adjusted
using the Bonferroni, Holm–Bonferroni, or Benjamini–Hochberg
procedure (the classic False Discovery Rate, FDR).<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref></sup> The ORA was performed at each level of the nomenclature hierarchy
and on structural features provided by Goslin to correct for the set
size effect.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Additional parameters (grouped
number of carbon atoms per acyl chain: less than 16, 16–18,
and more than 18; and the number of double bonds: 0, saturated; 1,
monounsaturated; 2 and more, polyunsaturated) were included to facilitate
biological interpretation of the data. UpSet plots provide visualization
of term intersections.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The visualization
of nomenclature levels was implemented via Biopython.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> The lipidome was converted to phyloXML format, an XML language
designed to describe phylogenetic trees (or networks) and associated
data,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> and the pseudophylogenetic distances
(radii of the spheres/levels) were optimized for the hierarchical
structure of the lipidome. Only the CATEGORY and CLASS levels are
labeled to optimize space use and prevent overlapping labels. The
Cytoscape network was built to visualize the quantitative data and
statistics.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results</title>
    <sec id="sec3.1">
      <title>LORA, a Web-Based Tool for Lipid Over-Representation Analysis</title>
      <p>We developed LORA as a web-based interactive tool using Python
3.10, Dash, and Plotly packages.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> The application
uses a tabular layout. The query and reference lists of lipids are
uploaded, processed, and parsed via Goslin. Users can change the ORA
parameters, perform the analysis, interact with the plots, and download
the report (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). LORA is available as a web service (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://lora.metabolomics.fgu.cas.cz">https://lora.metabolomics.fgu.cas.cz</uri>), and the source code is hosted at GitHub <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/IPHYS-Bioinformatics/LORA">https://github.com/IPHYS-Bioinformatics/LORA</uri> under the terms of liberal open source licenses.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>LORA pipeline. User data
(reference and query lipid names) are
processed using Goslin. The lipidome is visualized as a dendrogram,
and LORA is performed. Enrichment results are summarized in a table,
which is further processed to a lipid network and an UpSet plot.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0001" id="gr1" position="float"/>
      </fig>
      <p>The primary output of ORA is a set of over-represented
terms. The
terms are defined based on the nomenclature levels and structural
characteristics of the lipidome parsed by Goslin, e.g., “Total
number of carbon atoms”, “Fatty acid #1 <italic>sn</italic> position”, Total #O, etc.</p>
      <p>LORA is the first tool that
uses smart text mining and extracts
all available structural information from a provided lipid identifier.
Therefore, enrichment based on double bond positions (location and
conformation), bond type (ester and ether), and modifications (oxidized
and cyclized) can be calculated. Human adipose tissue lipidomes (DEMO
1 and DEMO 2) demonstrate how LORA mines the information from widely
used LC–MS lipidomic pipelines.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref></sup> The human
lung lipidome data set in DEMO 3 comes from Lipid Mini-On test files.
The technical DEMO 4 data set contains a collection of (modified)
lipids defined up to “Complete structure” to illustrate
the potential use.</p>
    </sec>
    <sec id="sec3.2">
      <title>Shared Structural Characteristics of Over-Represented Lipids</title>
      <p>The idea behind ORA is that we can infer a smaller set of structural
characteristics for a set of significantly altered lipids, which reduces
the dimensionality and defines the essential features of the query
data. However, we can also take the sets of structural characteristics,
explore their intersections, and find the lipid molecule(s) that best
represent the set of significantly altered lipids. The lipids present
in the most over-represented terms (lipids with the highest number
of term intersections) are defined as Very Important Lipids (VILs). <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> show the analysis of DEMO
4. <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> defines
the seven over-represented terms, and the UpSet plot in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> highlights the common patterns.
The green cluster defines 13 lipids that share structural features
in four over-represented terms (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> B and C). For example, one output is “The query
lipids are statistically significantly enriched in glycerophospholipids
containing 20:4 acyl at the <italic>sn</italic>-2 position”.</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Summary of Over-Represented Terms
from DEMO 4 Calculated at Alpha Level 0.001 with FDR Correction</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">Term (Group/Classifier)</th>
              <th style="border:none;" align="center">Goslin Level</th>
              <th style="border:none;" align="center">No. Query</th>
              <th style="border:none;" align="center">No. Reference</th>
              <th style="border:none;" align="center"><italic>p</italic>-value</th>
              <th style="border:none;" align="center">Odds Ratio</th>
              <th style="border:none;" align="center">FDR</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;">Acyls 16:1</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">18/556</td>
              <td style="border:none;">4.30e-06</td>
              <td style="border:none;">7.0646</td>
              <td style="border:none;">0</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">15/68</td>
              <td style="border:none;">26/556</td>
              <td style="border:none;">5.44e-06</td>
              <td style="border:none;">5.7692</td>
              <td style="border:none;">0</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4</td>
              <td style="border:none;">SN POSITION</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">19/556</td>
              <td style="border:none;">6.63e-06</td>
              <td style="border:none;">6.6804</td>
              <td style="border:none;">0.0001</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 16:1 within Glycerophospholipids [GP]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">17/448</td>
              <td style="border:none;">2.36e-05</td>
              <td style="border:none;">5.9925</td>
              <td style="border:none;">0.0002</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4 within Glycerophospholipids
[GP]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">15/68</td>
              <td style="border:none;">24/448</td>
              <td style="border:none;">2.86e-05</td>
              <td style="border:none;">5.0000</td>
              <td style="border:none;">0.0002</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 20:4 within Glycerophospholipids
[GP]</td>
              <td style="border:none;">SN POSITION</td>
              <td style="border:none;">13/68</td>
              <td style="border:none;">18/448</td>
              <td style="border:none;">3.64e-05</td>
              <td style="border:none;">5.6465</td>
              <td style="border:none;">0.0004</td>
            </tr>
            <tr>
              <td style="border:none;">Acyls 16:1 within Glycerophosphocholines [GP01]</td>
              <td style="border:none;">MOLECULAR SPECIES</td>
              <td style="border:none;">11/26</td>
              <td style="border:none;">14/148</td>
              <td style="border:none;">1.00e-4</td>
              <td style="border:none;">7.0190</td>
              <td style="border:none;">0.0005</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Interpretation of the LORA results. (A) UpSet plot showing the
intersection of over-represented terms (structural characteristics)
from <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. Cardinality
is sorted according to the total number of term intersections. (B)
Intersection of four terms defining the green cluster. (C) Green cluster
containing 13 lipids which share a structural feature “20:4”
at the <italic>sn</italic>-2 position.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_0002" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec3.3">
      <title>UpSet plot Visualization of Term Intersections</title>
      <p>The
major challenge in evaluating the over-represented structural characteristics
is the enormous number of set intersections if the number of sets
exceeds a reasonable threshold. In the case of one to three sets,
the Venn or Euler diagrams, which visualize all possible logical relations
between the sets, can be used. In the case of two to 20 sets, the
UpSet plot provides a comprehensive visualization.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The UpSet plot helps identify the main structural features
of enriched lipids and highlights the VILs in a graphical representation
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Connected
black dots represent the intersection of the terms labeled on top.
The term intersection size (cardinality bar plot) represents the number
of lipids that have this specific set of structural features in common.
The <italic>p</italic>-values belong to the particular lipids within
individual terms (<italic>n</italic> lipids × <italic>m</italic> terms). The bar graph at the bottom shows how many lipids belong
to the term. The plot is interactive, and a table showing all lipids
within the specific intersection (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C) is generated upon clicking on the cardinality
bar.</p>
    </sec>
    <sec id="sec3.4">
      <title>Hierarchical Tree Visualization of the Lipidome</title>
      <p>Goslin
provides information on the hierarchical level of the lipids in the
data set. We can visualize the information as a circular tree map
(dendrogram) showing part-to-whole relationships and the level of
structural details provided by the analytical method. The graph itself
is interactive, and each lipid level can be explored via a tooltip
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Figure S1A</ext-link>). The lipidome enrichment down
to the LIPID MAPS SUBCLASS level can be visualized as an interactive
network in Cytoscape, which allows for the mapping of statistical
data onto nodes and edges (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">Figure S1B</ext-link>).</p>
    </sec>
    <sec id="sec3.5">
      <title>Report</title>
      <p>LORA provides output in a zip archive containing
a PDF report, parameter settings, over-representation analysis results,
VIL table, UpSet plot, intersection tables, circular tree map, and
the lipidome network in SVG, JPG, phyloXML, interactive HTML, XLSX,
and Cytoscape formats, respectively.</p>
    </sec>
    <sec id="sec3.6">
      <title>Limitations</title>
      <p>Lipid modifications, including oxidation,
nitration, or halogenation, represent a new level of nomenclature
complexity that extremely expands the search space.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Testing all structural characteristics up to “Complete
structure level” would require computational resources that
would not balance information gain. Therefore, the application does
not implement “rare” features like the position of lipid
modification or enantiomers. Lipid names in conflict with the hierarchical
structure of shorthand notation (e.g., PC 16:1(7)_16:1(9)) will be
converted to the closest valid level (e.g., PC 16:1_16:1). Goslin
grammars (version 2) are currently limited to the most common set
of lipid classes and do not consider multiple class categorization
of lipids in LIPID MAPS (e.g., [FA01] Fatty Acid Conjugates and [FA02]
Octadecanoids).<sup><xref ref-type="bibr" rid="ref11">11</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Discussion and Conclusion</title>
    <p>Lipidomic analyses are usually
performed to gain insight into system
lipid metabolism, and ORA helps reduce the observation’s dimensionality.
In contrast to transcriptomics, where the ORA results can be directly
used in pathways analysis,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> functional
pathway schemes for lipids are largely unavailable. The major problems
are (1) the inability to assign a lipid database identifier to experimentally
generated information describing the lipid molecule at the level of
enzyme–substrate specificity,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> (2)
the continuous remodeling of the head groups and acyl chains by many
enzymes simultaneously, and (3) the lack of curated lipid pathways
at various nomenclature levels (with a few exceptions<sup><xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup>). Generalized databases such as KEGG do not consider the structural
diversity of lipids and often blur together multiple biological processes,
thus compromising the biological interpretation. To overcome the problems,
LORA builds on the Goslin standardization approach and known lipid
structural characteristics provided by novel analytical techniques.
Instead of relying on predefined schemes, LORA creates a set of over-represented
terms based solely on provided structural information and statistical
tests. The user can either directly interpret this set or reshape
it by the UpSet plot to highlight the most common structural features
and their representatives (lipid species).</p>
    <p>The most common set
visualization approach—Venn diagrams—do
not scale beyond three or four sets. The UpSet plot, in contrast,
is well suited for the quantitative analysis of data with more than
three sets. When more than seven sets intersect, the advanced UpSet
plots allowing aggregation and grouping should be used to reduce the
dimensionality.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> We optimized the UpSet
plot implemented in LORA for common lipidomics data sets. We limited
the visualization to at most 13 terms because the calculation costs
of all possible term intersections grow exponentially. Of note, the
choice of lipid structural features, similar to the pathway database,
used in ORA can have a much stronger effect on the enrichment results
than the statistical corrections used in these analyses.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup></p>
    <p>LORA is a tool focused on the expanding
technologies in (epi)lipidomics
that allow for more precise identification of lipid structures. Routine
use of supercritical fluid chromatography, ion mobility spectrometry,
ion–molecule reactions, or derivatization techniques to specifically
target double bond positions will provide further levels of detail
to lead toward the full structural characterization of lipids. LORA
mines this information-rich data set and helps interpret lipid structural
features and over-represented terms using visualization tools. It
is the next step toward understanding lipidomic data sets at the molecular
level.</p>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The
Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.analchem.3c02039?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.3c02039</ext-link>.<list id="silist" list-type="simple"><list-item><p>Supplementary figures and texts (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.analchem.3c02039/suppl_file/ac3c02039_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac3c02039_si_001.pdf">
        <caption>
          <p>ac3c02039_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes2">
    <title>Author Contributions</title>
    <p>Conceptualization:
O.K. Data curation: M.V. and O.K. Formal analysis: M.V., D.K., and
N.H. Funding acquisition: O.K. Investigation: M.V. and O.K. Methodology:
M.V. and O.K. Project administration: O.K. Resources: D.K., N.H.,
and O.K. Software: M.V., D.K., N.H., and O.K. Supervision: O.K. Validation:
D.K. and N.H. Visualization: M.V. and O.K. Writing–original
draft: M.V. and O.K. Writing–review and editing: M.V., N.H.,
and O.K.</p>
  </notes>
  <notes notes-type="COI-statement" id="notes3">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work is supported by the project National Institute
for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES,
ID Project No. LX22NPO5104) – Funded by the European Union
– Next Generation EU, Ministry of Health [NV19-02-00118], the
Czech Academy of Sciences [Lumina Quaeruntur LQ200111901], and COST
Action CA19105 - Pan-European Network in Lipidomics and EpiLipidomics
(EpiLipidNET), supported by COST (European Cooperation in Science
and Technology).</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Šala</surname><given-names>M.</given-names></name>; <name><surname>Lísa</surname><given-names>M.</given-names></name>; <name><surname>Campbell</surname><given-names>J. L.</given-names></name>; <name><surname>Holčapek</surname><given-names>M.</given-names></name><article-title>Determination
of triacylglycerol regioisomers using differential mobility spectrometry</article-title>. <source>Rapid Commun. Mass Spectrom.</source><year>2016</year>, <volume>30</volume>, <fpage>256</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1002/rcm.7430</pub-id>.<pub-id pub-id-type="pmid">27071217</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Menzel</surname><given-names>J. P.</given-names></name>; <name><surname>Young</surname><given-names>R. S. E.</given-names></name>; <name><surname>Benfield</surname><given-names>A. H.</given-names></name>; <name><surname>Scott</surname><given-names>J. S.</given-names></name>; <name><surname>Wongsomboon</surname><given-names>P.</given-names></name>; <name><surname>Cudlman</surname><given-names>L.</given-names></name>; <name><surname>Cvacka</surname><given-names>J.</given-names></name>; <name><surname>Butler</surname><given-names>L. M.</given-names></name>; <name><surname>Henriques</surname><given-names>S. T.</given-names></name>; <name><surname>Poad</surname><given-names>B. L. J.</given-names></name>; <name><surname>Blanksby</surname><given-names>S. J.</given-names></name><article-title>Ozone-enabled
fatty acid discovery
reveals unexpected diversity in the human lipidome</article-title>. <source>Nat. Commun.</source><year>2023</year>, <volume>14</volume>, <fpage>3940</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-39617-9</pub-id>.<pub-id pub-id-type="pmid">37402773</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Ren</surname><given-names>H.</given-names></name>; <name><surname>Triebl</surname><given-names>A.</given-names></name>; <name><surname>Muralidharan</surname><given-names>S.</given-names></name>; <name><surname>Wenk</surname><given-names>M. R.</given-names></name>; <name><surname>Xia</surname><given-names>Y.</given-names></name>; <name><surname>Torta</surname><given-names>F.</given-names></name><article-title>Mapping the distribution
of double bond location isomers in lipids
across mouse tissues</article-title>. <source>Analyst</source><year>2021</year>, <volume>146</volume>, <fpage>3899</fpage>–<lpage>3907</lpage>. <pub-id pub-id-type="doi">10.1039/D1AN00449B</pub-id>.<pub-id pub-id-type="pmid">34009216</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Brezinova</surname><given-names>M.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name>; <name><surname>Hansikova</surname><given-names>J.</given-names></name>; <name><surname>Rombaldova</surname><given-names>M.</given-names></name>; <name><surname>Balas</surname><given-names>L.</given-names></name>; <name><surname>Bardova</surname><given-names>K.</given-names></name>; <name><surname>Durand</surname><given-names>T.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Cerna</surname><given-names>M.</given-names></name>; <name><surname>Stranak</surname><given-names>Z.</given-names></name>; <name><surname>Kopecky</surname><given-names>J.</given-names></name><article-title>Levels of
palmitic
acid ester of hydroxystearic acid (PAHSA) are reduced in the breast
milk of obese mothers</article-title>. <source>BBA MCBL</source><year>2018</year>, <volume>1863</volume>, <fpage>126</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2017.11.004</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Hancock</surname><given-names>S. E.</given-names></name>; <name><surname>Poad</surname><given-names>B. L.</given-names></name>; <name><surname>Batarseh</surname><given-names>A.</given-names></name>; <name><surname>Abbott</surname><given-names>S. K.</given-names></name>; <name><surname>Mitchell</surname><given-names>T. W.</given-names></name><article-title>Advances
and unresolved challenges in the structural characterization of isomeric
lipids</article-title>. <source>Anal. Biochem.</source><year>2017</year>, <volume>524</volume>, <fpage>45</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2016.09.014</pub-id>.<pub-id pub-id-type="pmid">27651163</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Liebisch</surname><given-names>G.</given-names></name>; <name><surname>Fahy</surname><given-names>E.</given-names></name>; <name><surname>Aoki</surname><given-names>J.</given-names></name>; <name><surname>Dennis</surname><given-names>E. A.</given-names></name>; <name><surname>Durand</surname><given-names>T.</given-names></name>; <name><surname>Ejsing</surname><given-names>C. S.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name>; <name><surname>Feussner</surname><given-names>I.</given-names></name>; <name><surname>Griffiths</surname><given-names>W. J.</given-names></name>; <name><surname>Kofeler</surname><given-names>H.</given-names></name>; <name><surname>Merrill</surname><given-names>A. H.</given-names><suffix>Jr</suffix></name>; <name><surname>Murphy</surname><given-names>R. C.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name>; <name><surname>Oskolkova</surname><given-names>O.</given-names></name>; <name><surname>Subramaniam</surname><given-names>S.</given-names></name>; <name><surname>Wakelam</surname><given-names>M. J. O.</given-names></name>; <name><surname>Spener</surname><given-names>F.</given-names></name><article-title>Update on
LIPID MAPS classification,
nomenclature, and shorthand notation for MS-derived lipid structures</article-title>. <source>J. Lipid Res.</source><year>2020</year>, <volume>61</volume>, <fpage>1539</fpage>–<lpage>1555</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.S120001025</pub-id>.<pub-id pub-id-type="pmid">33037133</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Damiani</surname><given-names>T.</given-names></name>; <name><surname>Bonciarelli</surname><given-names>S.</given-names></name>; <name><surname>Thallinger</surname><given-names>G. G.</given-names></name>; <name><surname>Koehler</surname><given-names>N.</given-names></name>; <name><surname>Krettler</surname><given-names>C. A.</given-names></name>; <name><surname>Salihoglu</surname><given-names>A. K.</given-names></name>; <name><surname>Korf</surname><given-names>A.</given-names></name>; <name><surname>Pauling</surname><given-names>J. K.</given-names></name>; <name><surname>Pluskal</surname><given-names>T.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Goracci</surname><given-names>L.</given-names></name><article-title>Software and Computational Tools for LC-MS-Based Epilipidomics:
Challenges and Solutions</article-title>. <source>Anal. Chem.</source><year>2023</year>, <volume>95</volume>, <fpage>287</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.2c04406</pub-id>.<pub-id pub-id-type="pmid">36625108</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Molenaar</surname><given-names>M. R.</given-names></name>; <name><surname>Jeucken</surname><given-names>A.</given-names></name>; <name><surname>Wassenaar</surname><given-names>T. A.</given-names></name>; <name><surname>van de Lest</surname><given-names>C. H. A.</given-names></name>; <name><surname>Brouwers</surname><given-names>J. F.</given-names></name>; <name><surname>Helms</surname><given-names>J. B.</given-names></name><article-title>LION/web: a web-based
ontology enrichment
tool for lipidomic data analysis</article-title>. <source>Gigascience</source><year>2019</year>, <volume>8</volume>, <fpage>giz061</fpage><pub-id pub-id-type="doi">10.1093/gigascience/giz061</pub-id>.<pub-id pub-id-type="pmid">31141612</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Clair</surname><given-names>G.</given-names></name>; <name><surname>Reehl</surname><given-names>S.</given-names></name>; <name><surname>Stratton</surname><given-names>K. G.</given-names></name>; <name><surname>Monroe</surname><given-names>M. E.</given-names></name>; <name><surname>Tfaily</surname><given-names>M. M.</given-names></name>; <name><surname>Ansong</surname><given-names>C.</given-names></name>; <name><surname>Kyle</surname><given-names>J. E.</given-names></name><article-title>Lipid Mini-On:
mining and ontology
tool for enrichment analysis of lipidomic data</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume>, <fpage>4507</fpage>–<lpage>4508</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz250</pub-id>.<pub-id pub-id-type="pmid">30977807</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Kopczynski</surname><given-names>D.</given-names></name>; <name><surname>Hoffmann</surname><given-names>N.</given-names></name>; <name><surname>Peng</surname><given-names>B.</given-names></name>; <name><surname>Ahrends</surname><given-names>R.</given-names></name><article-title>Goslin: A
Grammar of
Succinct Lipid Nomenclature</article-title>. <source>Anal. Chem.</source><year>2020</year>, <volume>92</volume>, <fpage>10957</fpage>–<lpage>10960</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.0c01690</pub-id>.<pub-id pub-id-type="pmid">32589019</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Kopczynski</surname><given-names>D.</given-names></name>; <name><surname>Hoffmann</surname><given-names>N.</given-names></name>; <name><surname>Peng</surname><given-names>B.</given-names></name>; <name><surname>Liebisch</surname><given-names>G.</given-names></name>; <name><surname>Spener</surname><given-names>F.</given-names></name>; <name><surname>Ahrends</surname><given-names>R.</given-names></name><article-title>Goslin 2.0 Implements
the Recent Lipid Shorthand Nomenclature
for MS-Derived Lipid Structures</article-title>. <source>Anal. Chem.</source><year>2022</year>, <volume>94</volume>, <fpage>6097</fpage>–<lpage>6101</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.1c05430</pub-id>.<pub-id pub-id-type="pmid">35404045</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="report" id="cit12"><person-group><name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name></person-group><article-title>LipidLynxX: a data transfer
hub to support integration
of large scale lipidomics datasets</article-title>. <source>bioRxiv
Preprint</source>, <year>2020</year>. <pub-id pub-id-type="doi">10.1101/2020.04.09.033894</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Janovska</surname><given-names>P.</given-names></name>; <name><surname>Melenovsky</surname><given-names>V.</given-names></name>; <name><surname>Svobodova</surname><given-names>M.</given-names></name>; <name><surname>Havlenova</surname><given-names>T.</given-names></name>; <name><surname>Kratochvilova</surname><given-names>H.</given-names></name>; <name><surname>Haluzik</surname><given-names>M.</given-names></name>; <name><surname>Hoskova</surname><given-names>E.</given-names></name>; <name><surname>Pelikanova</surname><given-names>T.</given-names></name>; <name><surname>Kautzner</surname><given-names>J.</given-names></name>; <name><surname>Monzo</surname><given-names>L.</given-names></name>; <name><surname>Jurcova</surname><given-names>I.</given-names></name>; <name><surname>Adamcova</surname><given-names>K.</given-names></name>; <name><surname>Lenkova</surname><given-names>L.</given-names></name>; <name><surname>Buresova</surname><given-names>J.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name>; <name><surname>Cajka</surname><given-names>T.</given-names></name>; <name><surname>Kopecky</surname><given-names>J.</given-names></name><article-title>Dysregulation of epicardial
adipose tissue in cachexia due to heart failure: the role of natriuretic
peptides and cardiolipin</article-title>. <source>J. Cachexia Sarcopenia
Muscle</source><year>2020</year>, <volume>11</volume>, <fpage>1614</fpage>–<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1002/jcsm.12631</pub-id>.<pub-id pub-id-type="pmid">33084249</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Lange</surname><given-names>M.</given-names></name>; <name><surname>Angelidou</surname><given-names>G.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Criscuolo</surname><given-names>A.</given-names></name>; <name><surname>Schiller</surname><given-names>J.</given-names></name>; <name><surname>Bluher</surname><given-names>M.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name><article-title>AdipoAtlas:
A reference
lipidome for human white adipose tissue</article-title>. <source>Cell
Rep. Med.</source><year>2021</year>, <volume>2</volume>, <fpage>100407</fpage><pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100407</pub-id>.<pub-id pub-id-type="pmid">34755127</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Lauder</surname><given-names>S. N.</given-names></name>; <name><surname>Allen-Redpath</surname><given-names>K.</given-names></name>; <name><surname>Slatter</surname><given-names>D. A.</given-names></name>; <name><surname>Aldrovandi</surname><given-names>M.</given-names></name>; <name><surname>O’Connor</surname><given-names>A.</given-names></name>; <name><surname>Farewell</surname><given-names>D.</given-names></name>; <name><surname>Percy</surname><given-names>C. L.</given-names></name>; <name><surname>Molhoek</surname><given-names>J. E.</given-names></name>; <name><surname>Rannikko</surname><given-names>S.</given-names></name>; <name><surname>Tyrrell</surname><given-names>V. J.</given-names></name>; <name><surname>Ferla</surname><given-names>S.</given-names></name>; <name><surname>Milne</surname><given-names>G. L.</given-names></name>; <name><surname>Poole</surname><given-names>A. W.</given-names></name>; <name><surname>Thomas</surname><given-names>C. P.</given-names></name>; <name><surname>Obaji</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>P. R.</given-names></name>; <name><surname>Jones</surname><given-names>S. A.</given-names></name>; <name><surname>de Groot</surname><given-names>P. G.</given-names></name>; <name><surname>Urbanus</surname><given-names>R. T.</given-names></name>; <name><surname>Horkko</surname><given-names>S.</given-names></name>; <name><surname>Uderhardt</surname><given-names>S.</given-names></name>; <name><surname>Ackermann</surname><given-names>J.</given-names></name>; <name><surname>Vince Jenkins</surname><given-names>P.</given-names></name>; <name><surname>Brancale</surname><given-names>A.</given-names></name>; <name><surname>Kronke</surname><given-names>G.</given-names></name>; <name><surname>Collins</surname><given-names>P. W.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name><article-title>Networks
of enzymatically oxidized membrane lipids support calcium-dependent
coagulation factor binding to maintain hemostasis</article-title>. <source>Sci. Signal</source><year>2017</year>, <volume>10</volume>, <fpage>eaan2787</fpage><pub-id pub-id-type="doi">10.1126/scisignal.aan2787</pub-id>.<pub-id pub-id-type="pmid">29184033</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Virtanen</surname><given-names>P.</given-names></name>; <name><surname>Gommers</surname><given-names>R.</given-names></name>; <name><surname>Oliphant</surname><given-names>T. E.</given-names></name>; <name><surname>Haberland</surname><given-names>M.</given-names></name>; <name><surname>Reddy</surname><given-names>T.</given-names></name>; <name><surname>Cournapeau</surname><given-names>D.</given-names></name>; <name><surname>Burovski</surname><given-names>E.</given-names></name>; <name><surname>Peterson</surname><given-names>P.</given-names></name>; <name><surname>Weckesser</surname><given-names>W.</given-names></name>; <name><surname>Bright</surname><given-names>J.</given-names></name>; <name><surname>van der Walt</surname><given-names>S. J.</given-names></name>; <name><surname>Brett</surname><given-names>M.</given-names></name>; <name><surname>Wilson</surname><given-names>J.</given-names></name>; <name><surname>Millman</surname><given-names>K. J.</given-names></name>; <name><surname>Mayorov</surname><given-names>N.</given-names></name>; <name><surname>Nelson</surname><given-names>A. R. J.</given-names></name>; <name><surname>Jones</surname><given-names>E.</given-names></name>; <name><surname>Kern</surname><given-names>R.</given-names></name>; <name><surname>Larson</surname><given-names>E.</given-names></name>; <name><surname>Carey</surname><given-names>C. J.</given-names></name>; et al. <article-title>SciPy 1.0: fundamental algorithms for scientific
computing in Python</article-title>. <source>Nat. Methods</source><year>2020</year>, <volume>17</volume>, <fpage>261</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id>.<pub-id pub-id-type="pmid">32015543</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Chen</surname><given-names>S. Y.</given-names></name>; <name><surname>Feng</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>X.</given-names></name><article-title>A general
introduction to adjustment
for multiple comparisons</article-title>. <source>J. Thorac. Dis.</source><year>2017</year>, <volume>9</volume>, <fpage>1725</fpage>–<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.21037/jtd.2017.05.34</pub-id>.<pub-id pub-id-type="pmid">28740688</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Huang</surname><given-names>D. W.</given-names></name>; <name><surname>Sherman</surname><given-names>B. T.</given-names></name>; <name><surname>Lempicki</surname><given-names>R. A.</given-names></name><article-title>Bioinformatics
enrichment tools:
paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>, <volume>37</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id>.<pub-id pub-id-type="pmid">19033363</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Karp</surname><given-names>P. D.</given-names></name>; <name><surname>Midford</surname><given-names>P. E.</given-names></name>; <name><surname>Caspi</surname><given-names>R.</given-names></name>; <name><surname>Khodursky</surname><given-names>A.</given-names></name><article-title>Pathway size
matters: the influence of pathway granularity on over-representation
(enrichment analysis) statistics</article-title>. <source>BMC Genomics</source><year>2021</year>, <volume>22</volume>, <fpage>191</fpage><pub-id pub-id-type="doi">10.1186/s12864-021-07502-8</pub-id>.<pub-id pub-id-type="pmid">33726670</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Lex</surname><given-names>A.</given-names></name>; <name><surname>Gehlenborg</surname><given-names>N.</given-names></name>; <name><surname>Strobelt</surname><given-names>H.</given-names></name>; <name><surname>Vuillemot</surname><given-names>R.</given-names></name>; <name><surname>Pfister</surname><given-names>H.</given-names></name><article-title>UpSet: Visualization
of Intersecting Sets</article-title>. <source>IEEE Trans Vis Comput.
Graph</source><year>2014</year>, <volume>20</volume>, <fpage>1983</fpage>–<lpage>1992</lpage>. <pub-id pub-id-type="doi">10.1109/TVCG.2014.2346248</pub-id>.<pub-id pub-id-type="pmid">26356912</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Cock</surname><given-names>P. J.</given-names></name>; <name><surname>Antao</surname><given-names>T.</given-names></name>; <name><surname>Chang</surname><given-names>J. T.</given-names></name>; <name><surname>Chapman</surname><given-names>B. A.</given-names></name>; <name><surname>Cox</surname><given-names>C. J.</given-names></name>; <name><surname>Dalke</surname><given-names>A.</given-names></name>; <name><surname>Friedberg</surname><given-names>I.</given-names></name>; <name><surname>Hamelryck</surname><given-names>T.</given-names></name>; <name><surname>Kauff</surname><given-names>F.</given-names></name>; <name><surname>Wilczynski</surname><given-names>B.</given-names></name>; <name><surname>de Hoon</surname><given-names>M. J.</given-names></name><article-title>Biopython: freely
available Python tools for computational molecular biology and bioinformatics</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>1422</fpage>–<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp163</pub-id>.<pub-id pub-id-type="pmid">19304878</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Han</surname><given-names>M. V.</given-names></name>; <name><surname>Zmasek</surname><given-names>C. M.</given-names></name><article-title>phyloXML: XML for evolutionary biology
and comparative
genomics</article-title>. <source>BMC Bioinformatics</source><year>2009</year>, <volume>10</volume>, <fpage>356</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-356</pub-id>.<pub-id pub-id-type="pmid">19860910</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Lopes</surname><given-names>M.</given-names></name>; <name><surname>Brejchova</surname><given-names>K.</given-names></name>; <name><surname>Riecan</surname><given-names>M.</given-names></name>; <name><surname>Novakova</surname><given-names>M.</given-names></name>; <name><surname>Rossmeisl</surname><given-names>M.</given-names></name>; <name><surname>Cajka</surname><given-names>T.</given-names></name>; <name><surname>Kuda</surname><given-names>O.</given-names></name><article-title>Metabolomics atlas
of oral 13C-glucose
tolerance test in mice</article-title>. <source>Cell Rep.</source><year>2021</year>, <volume>37</volume>, <fpage>109833</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109833</pub-id>.<pub-id pub-id-type="pmid">34644567</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="book" id="cit24"><person-group person-group-type="allauthors"><name><surname>Van Rossum</surname><given-names>G.</given-names></name>; <name><surname>Drake</surname><given-names>F. L.</given-names></name></person-group><source>Python 3 Reference
Manual</source>; <publisher-name>CreateSpace</publisher-name>: <publisher-loc>Scotts Valley, CA</publisher-loc>, <year>2009</year>.</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="book" id="cit25"><person-group person-group-type="allauthors"><name><surname>Sievert</surname><given-names>C.</given-names></name></person-group><source>Interactive Web-Based
Data Visualization with R, plotly, and shiny</source>; <publisher-name>Chapman and Hall/CRC</publisher-name>: <publisher-loc>FL</publisher-loc>, <year>2020</year>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Martens</surname><given-names>M.</given-names></name>; <name><surname>Ammar</surname><given-names>A.</given-names></name>; <name><surname>Riutta</surname><given-names>A.</given-names></name>; <name><surname>Waagmeester</surname><given-names>A.</given-names></name>; <name><surname>Slenter</surname><given-names>D. N.</given-names></name>; <name><surname>Hanspers</surname><given-names>K.</given-names></name>; <name><surname>Miller</surname><given-names>R. A.</given-names></name>; <name><surname>Digles</surname><given-names>D.</given-names></name>; <name><surname>Lopes</surname><given-names>E. N.</given-names></name>; <name><surname>Ehrhart</surname><given-names>F.</given-names></name>; <name><surname>Dupuis</surname><given-names>L. J.</given-names></name>; <name><surname>Winckers</surname><given-names>L. A.</given-names></name>; <name><surname>Coort</surname><given-names>S. L.</given-names></name>; <name><surname>Willighagen</surname><given-names>E. L.</given-names></name>; <name><surname>Evelo</surname><given-names>C. T.</given-names></name>; <name><surname>Pico</surname><given-names>A. R.</given-names></name>; <name><surname>Kutmon</surname><given-names>M.</given-names></name><article-title>WikiPathways: connecting
communities</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D613</fpage>–<lpage>D621</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1024</pub-id>.<pub-id pub-id-type="pmid">33211851</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Gaud</surname><given-names>C.</given-names></name>; <name><surname>Sousa</surname><given-names>B. C.</given-names></name>; <name><surname>Nguyen</surname><given-names>A.</given-names></name>; <name><surname>Fedorova</surname><given-names>M.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>O’Donnell</surname><given-names>V. B.</given-names></name>; <name><surname>Wakelam</surname><given-names>M. J. O.</given-names></name>; <name><surname>Andrews</surname><given-names>S.</given-names></name>; <name><surname>Lopez-Clavijo</surname><given-names>A. F.</given-names></name><article-title>BioPAN:
a web-based tool to explore mammalian lipidome metabolic pathways
on LIPID MAPS</article-title>. <source>F1000Res.</source><year>2021</year>, <volume>10</volume>, <fpage>4</fpage><pub-id pub-id-type="doi">10.12688/f1000research.28022.2</pub-id>.<pub-id pub-id-type="pmid">33564392</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
